In a deeply concerning incident, a young woman from Bradford, Kelsey Scott, was administered a triple dose of epilepsy medication, highlighting the critical importance of patient safety and the need for robust safeguarding measures in healthcare settings. This incident, which occurred at the Bradford Royal Infirmary (BRI) in June, has left Kelsey's family devastated and has raised serious questions about the care standards for vulnerable patients.
Kelsey, who is non-verbal and relies on others for her care, was admitted to the hospital after suffering a cardiac arrest. Her complex medical needs, including CLN3 (Juvenile Batten disease), childhood dementia, and severe visual impairment, required meticulous management. However, a tragic mistake in medication administration has now put her life at risk.
The error occurred when the hospital pharmacy mislabelled and mis-dispensed her medication, resulting in Kelsey receiving 300mg tablets instead of the prescribed 100mg tablets. This led to her being given a dose more than triple the prescribed amount, both morning and evening, on two consecutive days. The consequences of this error were severe, with Kelsey experiencing prolonged seizures and sustaining bruising from striking her unprotected bed during these episodes.
Katie Brown, Kelsey's mother, expressed her shock and devastation at the incident. She stated that the error had shattered her confidence in the hospital's safeguarding procedures and raised concerns about the care standards for vulnerable patients. Mrs. Brown, who has worked in the care sector, believes that the error highlights deeper failures in safeguarding and patient care, including issues with medication dispensing, labelling, and verification.
The family was notified of the medication error on July 2, although the error was identified two days earlier. Mrs. Brown believes that she should have been informed immediately to fully understand the risks to her daughter's health and the action being taken. The incident has also brought to light other concerns, such as the suitability of Kelsey's room and bed, which were raised by her carers when she was first admitted to Ward 23.
The Bradford Teaching Hospitals NHS Foundation Trust has launched an investigation into the incident and has apologised to Kelsey and her family. They are working closely with the Medical and Healthcare products Regulatory Agency (MHRA) and are committed to learning from the incident to ensure that families are fully informed and that patient safety is maintained.
However, the tragic outcome of this incident has left Kelsey's health deteriorating. On July 8, Mrs. Brown reported that Kelsey had contracted a chest infection, and on July 10, she was transferred to a hospice to receive end-of-life treatment. This devastating turn of events underscores the urgent need for healthcare providers to prioritize patient safety and implement robust safeguards to prevent such incidents from occurring in the future.
Kelsey's story serves as a stark reminder of the importance of patient advocacy and the need for healthcare systems to be transparent and accountable. Vulnerable patients, who cannot communicate or advocate for themselves, deserve the highest standard of care, and families should never have to question their loved one's safety in hospital settings. By speaking out and raising awareness, Mrs. Brown hopes to prevent similar incidents and ensure that lessons are learned to strengthen safeguarding procedures.
